1. Home
  2. RGCO vs NERV Comparison

RGCO vs NERV Comparison

Compare RGCO & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

N/A

Current Price

$22.50

Market Cap

249.5M

Sector

Utilities

ML Signal

N/A

NERV

Minerva Neurosciences Inc

N/A

Current Price

$4.20

Market Cap

210.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGCO
NERV
Founded
1912
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
249.5M
210.1M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
RGCO
NERV
Price
$22.50
$4.20
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
$22.70
$10.50
AVG Volume (30 Days)
10.1K
185.4K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
3.93%
N/A
EPS Growth
11.21
N/A
EPS
1.31
N/A
Revenue
$95,334,212.00
$41,175,600.00
Revenue This Year
$11.06
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$16.79
N/A
Revenue Growth
12.63
N/A
52 Week Low
$19.68
$1.76
52 Week High
$27.17
$12.46

Technical Indicators

Market Signals
Indicator
RGCO
NERV
Relative Strength Index (RSI) 41.20 43.03
Support Level $21.94 $3.80
Resistance Level $22.63 $4.59
Average True Range (ATR) 1.00 0.38
MACD -0.32 -0.01
Stochastic Oscillator 11.05 28.57

Price Performance

Historical Comparison
RGCO
NERV

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: